Atlas Trials

Safety, Tolerability and Pharmacokinetics of CSL360 in the Treatment of Acute Myeloid Leukemia

Clinical trial NCT00401739 · COMPLETED

Trial details

NCT number
NCT00401739
Sponsor
CSL Limited
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Acute Myeloid Leukemia (AML)
Start date
2006-12-01
Primary completion
2009-09-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.